3Cui L,Wu Y,Cen L,et al.Repair of articular cartilage defect in non-weight bearing areas using adipose derived stem cells loaded polyglycolic acid mesh.Biomaterials,2009,30(14):2683-2693.
4G(o)therstr(o)m C,Ringdén O,Westgren M,et al.Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells.Bone Marrow Transplant,2003,32(3):265-272.
5Munn DH,Zhou M,Attwood JT,et al.Prevention of allogeneic fetal rejection by tryptophan catabolism.Science,1998,281(5380):1191-1193.
6Troyer DL,Weiss ML.Wharton's jelly-derived cells are a primitive stromal cell population.Stem Cells,2008,26(3):591-599.
7Weiss ML,Anderson C,Medicetty S,et al.Immune properties of human umbilical cord Wharton's jelly-derived cells.Stem Cells,2008,26(11):2865-2874.
8Prasanna SJ,Gopalakrishnan D,Shankar SR,et al.Pro-inflammatory cytokines,IFNgamma and TNFalpha,influence immune properties of human bone marrow and Wharton jelly mesenchymalstem cells differentially.PLoS One,2010,5(2):e9016.
9Yang Q,Peng J,Guo Q,et al.A cartilage ECM-derived 3-Dporous acellular matrix scaffold for in vivo cartilage tissue engineeringwith PKH26-1abeled chondrogenic bone marrow-derived mesenchymal stem cells.Biomaterials,2008,29(15):2378-2387.
